DNA — Ginkgo Bioworks Holdings, Inc.
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agriculture, food, consumer products, and pharmaceuticals. Ginkgo Bioworks has a partnership with Selecta Biosciences, Inc. to develop ImmTOR technology platform. Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.
Company profile
- Sector: Healthcare
- Industry: Biotechnology
- Country: US
- Exchange: NYSE
- Employees: 834
- Website: https://www.ginkgobioworks.com
Latest SEC filings for DNA
- 10-Q — 2026-08-06
- 8-K — 2026-08-05
- 8-K — 2026-07-30
- 8-K — 2026-06-12
- 10-Q — 2026-05-07
- 8-K — 2026-05-07
- 8-K — 2026-04-07
- 8-K — 2026-02-27
- 10-K — 2026-02-26
- 8-K — 2026-02-26
Latest DNA news
- — Ginkgo Bioworks Holdings, Inc. (DNA) Stock Falls Amid Market Uptick: What Investors Need to Know (Zacks Investment Research)
- — Here's Why Ginkgo Bioworks Holdings, Inc. (DNA) Fell More Than Broader Market (Zacks Investment Research)
- — What's Going on With Ginkgo Bioworks Stock on Friday? (benzinga.com)
- — Araceli Biosciences und Ginkgo Bioworks ermöglichen die zelluläre Bildgebung in großem Maßstab für das „Lab-in-the-Loop"-System von Nebula (prnewswire.com)
- — Ginkgo Bioworks to Provide Autonomous Lab Access to NSF X-Labs Researchers, Contributing Cloud Lab Time and Protein Testing Services to $1.5 Billion Breakthrough Science Program (businesswire.com)
- — Araceli Biosciences y Ginkgo Bioworks incorporan la obtención de imágenes celulares al laboratorio de Nebula (prnewswire.com)
- — Araceli Biosciences and Ginkgo Bioworks Bring Cellular Imaging at Scale to Nebula's Lab-in-the-Loop (prnewswire.com)
- — Ginkgo Bioworks Holdings, Inc. (DNA) Falls More Steeply Than Broader Market: What Investors Need to Know (Zacks Investment Research)
- — Ginkgo Bioworks Holdings, Inc. (DNA) Falls More Steeply Than Broader Market: What Investors Need to Know (zacks.com)
- — Ginkgo Bioworks (NYSE:DNA) Hits New 1-Year High – Time to Buy?
Educational tool only — not investment advice.